| Serial Number | 97401213 |
| Word Mark | HYLORIS |
| Filing Date | Monday, May 9, 2022 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, October 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 3, 2024 |
| Goods and Services | Custom manufacture of cardiovascular pharmaceuticals and medicines for treatment of cardiovascular diseases by pharmaceutical compounders; providing technical information in the field of pharmaceutical manufacturing of cardiovascular pharmaceuticals; biomanufacturing for others, namely, manufacturing of cardiovascular pharmaceuticals using biological organisms in the manufacturing process |
| Goods and Services | Cardiovascular pharmaceuticals; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of cardiovascular and cardiopulmonary diseases and disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; none of the aforementioned for the treatment of non-cardiological inflammatory disorders |
| Goods and Services | Pharmaceutical research and development services in the field of cardiovascular and cardiopulmonary disease and disorders; Development of cardiovascular pharmaceutical preparations and medicines for the treatment of cardiovascular diseases; cardiovascular pharmaceutical products development; Laboratory research services in the field of pharmaceuticals and new products, namely, cardiovascular pharmaceutical and biotechnological products in the nature of cardiovascular pharmaceuticals; conducting early evaluations in the field of new cardiovascular pharmaceuticals; testing, inspection and research of cardiovascular pharmaceuticals; research and development in the biotechnology fields in relation to cardiovascular and cardiopulmonary diseases and disorders; technical consulting services in the fields of pharmaceutical research and development, biotechnology; technical consulting services in the field of scientific laboratory services, namely, laboratory testing, diagnostics; all the aforementioned in relation to cardio vascular and cardiopulmonary diseases and disorders |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 13, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 13, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 15, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Hyloris Pharmaceuticals SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | Liège 4000 BE |
| Event Date | Event Description |
| Thursday, May 12, 2022 | NEW APPLICATION ENTERED |
| Friday, May 13, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 31, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, October 31, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 31, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 31, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, October 31, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 31, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, November 18, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, November 18, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, November 18, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, February 27, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, March 15, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 15, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 15, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 15, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, March 17, 2023 | SUSPENSION LETTER WRITTEN |
| Friday, March 17, 2023 | LETTER OF SUSPENSION E-MAILED |
| Friday, March 17, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, September 18, 2023 | SUSPENSION INQUIRY WRITTEN |
| Monday, September 18, 2023 | INQUIRY TO SUSPENSION E-MAILED |
| Monday, September 18, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Wednesday, November 29, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, April 18, 2024 | ASSIGNED TO LIE |
| Thursday, April 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 9, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, May 9, 2024 | LETTER OF SUSPENSION E-MAILED |
| Thursday, May 9, 2024 | SUSPENSION LETTER WRITTEN |
| Monday, July 15, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, July 16, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 16, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 9, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, August 9, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, August 9, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 18, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |